Baron Health Care Fund Q1 2026 Portfolio Activity
During the quarter, we added 9 new positions and exited 11 positions, bringing the number of positions in the Fund to 41.
Baron Health Care Fund Q1 2026 Shareholder Letter
During the quarter ended March 31, 2026, Baron Health Care Fund® (the Fund) declined 6.97% (Institutional Shares), compared ...
Fox News
New option available for Alzheimer’s patients as FDA approves expanded drug use
The U.S. Food and Drug Administration has green-lit the first-ever non-antipsychotic drug treatment for agitation in Alzheimer’s disease patients. The drug, Auvelity, was originally FDA-approved in ...
Medscape
FDA Approves Next-Gen Agent for Mantle Cell Lymphoma
The FDA has granted accelerated approval to sonrotoclax (Beqalzi, BeOne Medicines), for the treatment of certain adults with relapsed or refractory mantle cell lymphoma (MCL). Specifically, the ...
HUB
FDA approves early warning system for sepsis
An early warning system for sepsis, one of the deadliest infections for hospital patients, has been approved for use by the U.S. Food and Drug Administration, one of the first AI-based medical tools ...
Medical Xpress
Nasal spray developed for prehospital emergency aid for ischemic stroke
A research team from Department of Pharmacology and Pharmacy at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in collaboration with the InnoHK Advanced Biomedical Instrumentation ...
Reuters
US FDA approves BeOne's drug for a type of blood cancer
May 13 (Reuters) - BeOne Medicines (688235.SS), opens new tab said on Wednesday that the U.S. Food and Drug Administration had approved its drug for a type ‌of blood cancer. The drug, branded as ...
Reuters
Johnson & Johnson says nipocalimab approved in China
SHANGHAI, May 21 (Reuters) - Johnson & Johnson's (JNJ.N), opens new tab nipocalimab treatment for a type of muscle-weakening disorder received approval from China's National ‌Medical Products ...
McKnight's Long-Term Care News
FDA approves AI-powered sepsis warning systems in hospitals
The Food and Drug Administration has approved a clinical AI technology used to detect early signs of sepsis, the Targeted Real-Time Early Warning System. “Few clinical AI systems can reason across the ...
The American Journal of Managed Care
FDA Approves First All-Oral Regimen for AML
Regulatory clearance creates an at-home, 28-day cycle option using oral decitabine/cedazuridine on days 1–5 plus venetoclax 400 mg daily after a ramp-up cycle. Efficacy signals in ASCERTAIN-V included ...
CBS News
Trump approves plan to fire FDA Commissioner Marty Makary, sources say
Ed O'Keefe is CBS News' senior White House and political correspondent reporting for all CBS News platforms. He's part of the team covering President Trump and covered all four years of Joe Biden's ...
Healio
FDA approves Inqovi oral combination therapy for newly diagnosed AML
Please provide your email address to receive an email when new articles are posted on . The FDA has approved the oral combination of decitabine/cedazuridine tablets with venetoclax for certain adults ...